Breakthrough in stem cell treatment for Parkinson's
Date: Nov-07-2014 In a major breakthrough for the treatment of Parkinson's disease,
researchers working with laboratory rats show it is possible to make
dopamine cells from embryonic stem cells and transplant them into the brain, replacing the cells lost to the disease.
Researchers say it is possible to make dopamine cells from human embryonic stem cells, paving the way for a new treatment for Parkinson's.
Parkinson's disease is caused by the gradual loss of dopamine-producing
cells in the brain. Dopamine is a brain chemical that, among other things,
helps regulate movement and emotional responses.
There is currently no cure for Parkinson's disease, but there are drugs
that can slow it down, and deep brain
stimulation can alleviate symptoms of Parkinson's in certain
patients.
Human embryonic stem cells - precursor cells that have the potential to
become any cell of the body - are a promising source of new dopamine cells,
but they have proved difficult to harness for this purpose.
Now, a breakthrough study from Lund University in Sweden shows it is
possible to get human embryonic stem cells to produce a new generation of
dopamine cells that behave like native dopamine cells when transplanted
into the brains of rats.
Study leader Malin Parmar, associate professor in Lund's Department of
Medicine, and colleagues report their findings in the journal Cell Stem
Cell.
"The study shows that the cells that we generate from
stem cells, they function equally as well as the cells that we find in the
brain," says Prof. Parmar.
The team says the new cells show all the properties and functions of the
dopamine neurons that are lost in Parkinson's disease, and the potentially
unlimited supply sourced from stem cell lines opens the door to clinical
application.
For their study, the researchers carried out experiments in rat models
of Parkinson's disease. To produce a rat model of Parkinson's, researchers
destroy the dopamine cells in one part of the rat's brain.
The experiments showed that dopamine cells made from human embryonic
stem cells, when transplanted into the rats' brains, behaved like native
dopamine cells. The authors note that the transplanted cells:
Survived in the long term and restored production of dopamine in the
brain
Functioned in a similar way to dopamine cells of the "human fetal
midbrain"
Are capable of producing long distance links to the correct parts of
the brain
The axons that they grow "meet the requirements for use in humans."
The researchers explain their findings further in the video below:
Next step is to prepare for human clinical trials
Commenting on the breakthrough, Prof. Parmar says:
"These cells have the same ability as the brain's
normal dopamine cells to not only reach, but also to connect to their target
area over longer distances. This has been our goal for some time, and the
next step is to produce the same cells under the necessary regulations for
human use."
The team hopes the new cells will be ready for testing in human trials
in about 3 years.
The authors note that their study shows "strong preclinical support"
for using dopamine cells made from human embryonic stem cells, using
approaches similar to those established with fetal cells for the treatment
of Parkinson's disease.
There has been some success with using fetal cells, but these are harder
to source and there are ethical concerns about taking tissue from aborted
fetuses.
The study was conducted at Lund University and MIRCen in Paris, France, as
part of the European Union networks NeuroStemCell and NeuroStemcellRepair.
Meanwhile, Medical News Today recently learned that Harvard
scientists found stem cells that release
cancer-killing toxins may offer a new way to treat brain tumors.
Written by Catharine Paddock PhD
Not to be reproduced without permission.
Follow @twitter
window.twttr = (function (d, s, id) {
var t, js, fjs = d.getElementsByTagName(s)[0];
if (d.getElementById(id)) return;
js = d.createElement(s); js.id = id;
js.src= "https://platform.twitter.com/widgets.js";
fjs.parentNode.insertBefore(js, fjs);
return window.twttr || (t = { _e: [], ready: function (f) { t._e.push(f) }
}(document, "script", "twitter-wjs"));
Courtesy: Medical News Today
Note: Any medical information available in this news section is not intended as a substitute for informed medical
advice and you should not take any action before consulting with a health care professional.